Durability of PARP Inhibition: Implications for Dose & Schedule as Single Agent & Combination Therapy

Time: 3:00 pm
day: Day Two


  • Understanding different PARPi doses and schedules are needed for single agent and combinations
  • Delving into how the durability of PARP inhibition differs for the approved PARPis
  • Is the MTD/Safe dose and schedule appropriate for the approved dose of a molecularly targeted agent?
  • Clinical implications and improving access
    This seminar will be streamed live at the event